Weave Bio Announces $10M in New Funding and Launch of Its AI-Powered Platform to Streamline Drafting, Reviewing & Submitting Regulatory Documents in Drug Development
May 30, 2024 06:00 AM Pacific Daylight Time NEW HAVEN, Conn.–(BUSINESS WIRE)–Weave Bio, an AI-native life sciences platform company, announced the public release of its flagship offering, AutoIND, and seed funding of $10M co-led by Innovation…